vs
Side-by-side financial comparison of DocGo Inc. (DCGO) and STEM, INC. (STEM). Click either name above to swap in a different company.
DocGo Inc. is the larger business by last-quarter revenue ($74.9M vs $47.1M, roughly 1.6× STEM, INC.). STEM, INC. runs the higher net margin — -33.9% vs -190.0%, a 156.1% gap on every dollar of revenue. On growth, STEM, INC. posted the faster year-over-year revenue change (-15.6% vs -38.0%). Over the past eight quarters, STEM, INC.'s revenue compounded faster (36.1% CAGR vs -37.5%).
DocGo Inc. is a U.S.-headquartered mobile healthcare and on-demand medical service provider. It offers a range of solutions including in-home urgent care, diagnostic testing, telehealth consultations, and corporate wellness programs, serving individual patients, health systems, enterprise clients, and public sector organizations across North America.
StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.
DCGO vs STEM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $74.9M | $47.1M |
| Net Profit | $-142.3M | $-16.0M |
| Gross Margin | — | 48.9% |
| Operating Margin | -139.6% | -17.7% |
| Net Margin | -190.0% | -33.9% |
| Revenue YoY | -38.0% | -15.6% |
| Net Profit YoY | -1761.4% | 68.8% |
| EPS (diluted) | $-1.36 | $-4.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $74.9M | $47.1M | ||
| Q3 25 | $70.8M | $38.2M | ||
| Q2 25 | $80.4M | $38.4M | ||
| Q1 25 | $96.0M | $32.5M | ||
| Q4 24 | $120.8M | $55.8M | ||
| Q3 24 | $138.7M | $29.3M | ||
| Q2 24 | $164.9M | $34.0M | ||
| Q1 24 | $192.1M | $25.5M |
| Q4 25 | $-142.3M | $-16.0M | ||
| Q3 25 | $-27.8M | $-23.8M | ||
| Q2 25 | $-11.2M | $202.5M | ||
| Q1 25 | $-9.4M | $-25.0M | ||
| Q4 24 | $-7.6M | $-51.1M | ||
| Q3 24 | $5.5M | $-148.3M | ||
| Q2 24 | $6.5M | $-582.3M | ||
| Q1 24 | $11.2M | $-72.3M |
| Q4 25 | — | 48.9% | ||
| Q3 25 | — | 35.5% | ||
| Q2 25 | — | 33.4% | ||
| Q1 25 | — | 32.4% | ||
| Q4 24 | — | -4.4% | ||
| Q3 24 | — | 21.2% | ||
| Q2 24 | — | 27.6% | ||
| Q1 24 | — | -95.0% |
| Q4 25 | -139.6% | -17.7% | ||
| Q3 25 | -59.3% | -33.6% | ||
| Q2 25 | -21.7% | -34.8% | ||
| Q1 25 | -14.6% | -65.0% | ||
| Q4 24 | -6.2% | -84.4% | ||
| Q3 24 | 7.3% | -493.2% | ||
| Q2 24 | 6.2% | -1705.5% | ||
| Q1 24 | 8.3% | -267.0% |
| Q4 25 | -190.0% | -33.9% | ||
| Q3 25 | -39.2% | -62.2% | ||
| Q2 25 | -13.9% | 527.8% | ||
| Q1 25 | -9.8% | -76.9% | ||
| Q4 24 | -6.3% | -91.6% | ||
| Q3 24 | 4.0% | -506.3% | ||
| Q2 24 | 4.0% | -1712.6% | ||
| Q1 24 | 5.8% | -283.9% |
| Q4 25 | $-1.36 | $-4.40 | ||
| Q3 25 | $-0.28 | $-2.84 | ||
| Q2 25 | $-0.11 | $-1.79 | ||
| Q1 25 | $-0.09 | $-0.15 | ||
| Q4 24 | $-0.03 | $-15.29 | ||
| Q3 24 | $0.05 | $-18.24 | ||
| Q2 24 | $0.06 | $-71.81 | ||
| Q1 24 | $0.10 | $-0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $51.0M | $48.9M |
| Total DebtLower is stronger | $235.6K | — |
| Stockholders' EquityBook value | $144.0M | $-249.4M |
| Total Assets | $217.1M | $308.9M |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $51.0M | $48.9M | ||
| Q3 25 | $73.4M | $43.1M | ||
| Q2 25 | $104.2M | $40.8M | ||
| Q1 25 | $79.0M | $58.6M | ||
| Q4 24 | $89.2M | $56.3M | ||
| Q3 24 | $89.5M | $75.4M | ||
| Q2 24 | $66.1M | $89.6M | ||
| Q1 24 | $41.2M | $112.8M |
| Q4 25 | $235.6K | — | ||
| Q3 25 | $249.9K | — | ||
| Q2 25 | $12.6K | — | ||
| Q1 25 | $15.1K | — | ||
| Q4 24 | $17.7K | — | ||
| Q3 24 | $47.7K | — | ||
| Q2 24 | $52.8K | — | ||
| Q1 24 | $60.1K | — |
| Q4 25 | $144.0M | $-249.4M | ||
| Q3 25 | $270.5M | $-235.7M | ||
| Q2 25 | $297.3M | $-214.1M | ||
| Q1 25 | $309.3M | $-417.5M | ||
| Q4 24 | $320.9M | $-398.4M | ||
| Q3 24 | $325.2M | $-344.1M | ||
| Q2 24 | $315.2M | $-203.2M | ||
| Q1 24 | $311.3M | $371.6M |
| Q4 25 | $217.1M | $308.9M | ||
| Q3 25 | $353.8M | $362.6M | ||
| Q2 25 | $408.3M | $379.2M | ||
| Q1 25 | $430.8M | $405.1M | ||
| Q4 24 | $455.6M | $437.4M | ||
| Q3 24 | $493.9M | $537.8M | ||
| Q2 24 | $488.2M | $691.5M | ||
| Q1 24 | $490.7M | $1.3B |
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | 0.00× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-10.5M | $8.2M |
| Free Cash FlowOCF − Capex | $-12.0M | — |
| FCF MarginFCF / Revenue | -16.0% | — |
| Capex IntensityCapex / Revenue | 2.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $29.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-10.5M | $8.2M | ||
| Q3 25 | $1.7M | $11.4M | ||
| Q2 25 | $33.6M | $-21.3M | ||
| Q1 25 | $9.7M | $8.5M | ||
| Q4 24 | $12.7M | $-14.7M | ||
| Q3 24 | $31.1M | $-9.4M | ||
| Q2 24 | $36.9M | $-11.9M | ||
| Q1 24 | $-10.6M | $-621.0K |
| Q4 25 | $-12.0M | — | ||
| Q3 25 | $782.6K | — | ||
| Q2 25 | $32.9M | — | ||
| Q1 25 | $8.2M | — | ||
| Q4 24 | $12.0M | — | ||
| Q3 24 | $30.2M | — | ||
| Q2 24 | $35.9M | — | ||
| Q1 24 | $-11.6M | — |
| Q4 25 | -16.0% | — | ||
| Q3 25 | 1.1% | — | ||
| Q2 25 | 40.9% | — | ||
| Q1 25 | 8.5% | — | ||
| Q4 24 | 9.9% | — | ||
| Q3 24 | 21.8% | — | ||
| Q2 24 | 21.7% | — | ||
| Q1 24 | -6.0% | — |
| Q4 25 | 2.0% | — | ||
| Q3 25 | 1.2% | — | ||
| Q2 25 | 0.9% | — | ||
| Q1 25 | 1.5% | — | ||
| Q4 24 | 0.6% | — | ||
| Q3 24 | 0.7% | — | ||
| Q2 24 | 0.6% | — | ||
| Q1 24 | 0.5% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.11× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 5.67× | — | ||
| Q2 24 | 5.65× | — | ||
| Q1 24 | -0.95× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DCGO
| Transportation Services Segment | $50.2M | 67% |
| Mobile Health Services Segment | $24.8M | 33% |
STEM
Segment breakdown not available.
